Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom.
Saved in:
| Title: | Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom. |
|---|---|
| Authors: | Samyshkin Y; IMS Health, 210 Pentonville Road, London, N1 9JY, UK, ysamyshkin@uk.imshealth.com., Kotchie RW, Mörk AC, Briggs AH, Bateman ED |
| Source: | The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2014 Jan; Vol. 15 (1), pp. 69-82. Date of Electronic Publication: 2013 Feb 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
